FDA Adverse Event Injury Summary report: N

COMP RVRS 25MM BSPLT HA+ADPTR

MDR report key: 24179959 · Received January 26, 2026

Report

Report Number
0001825034-2026-00205
Event Type
Injury
Date Received
January 26, 2026
Date of Event
December 31, 2025
Report Date
January 26, 2026
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KWS
UDI-DI
00880304532465
PMA / PMN Number
K193373
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(4): D10: ITEM # 405889, COMP RVS 2.7MM DIA DRL, LOT # 67339898. ITEM # 405883, COMP RVS 3.2MM DRL, LOT # 67405007. ITEM # 110003484, ACCESS 3.2MM THD STEINMANN 9, LOT # 67257664. ITEM # 110031419, CR PROLONG 36MM BRNG +3, LOT # 67338871. ITEM # 113637, COMP PRIMARY STEM 17MM MINI, LOT # 65218335. ITEM # 115310, COMP RVRS SHLDR GLNSP STD 36MM, LOT # J7960066. ITEM # 110031400, MINI TRAY +5MM COCR +0 OFFSET, LOT # 67063667. ITEM # 180551, COMP LK SCR 3.5HEX 4.75X20 ST, LOT # 67627424. ITEM # 180558, COMP NLK SCR 3.5HEX 4.75X20 ST, LOT # 67403907. ITEM # 180559, COMP NLK SCR 3.5HEX 4.75X25 ST, LOT # 67422159. ITEM # 115396, COMP RVS CNTRL 6.5X30MM ST/RST, LOT # 67418137. ITEM # 180550, COMP LK SCR 3.5HEX 4.75X15 ST, LOT # 67420035. CUSTOMER HAS INDICATED THAT THE PRODUCT IS IN PROCESS OF BEING RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED

Description of Event or Problem · 0

IT WAS REPORTED PATIENT UNDERWENT SHOULDER REVISION APPROXIMATELY 44 DAYS POST IMPLANTATION DUE TO TAPER DISASSOCIATION FROM BASEPLATE. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
245107 COMP RVRS 25MM BSPLT HA+ADPTR PROSTHESIS, SHOULDER KWS ZIMMER BIOMET, INC. 67158396 00880304532465

Patients

Seq Age Sex Outcome Treatment
1 NA Male Required Intervention| H SEE H11 NARRATIVE.